CXCR4 and neoplasm: Xia et al. indicated that cisatracurium could suppress the viability, metastasis, and tumor growth of CRC by regulating the CXCR4/let-7a-5p axis through the inhibition of the TGF-β/SMAD2/3 signaling pathway [25].